Biotech Values

[donotknowityet]

mcu medicure

Drbio,

The important issue you raise is that Medicaure has a rich pipeline. Currently the company has enough money to complete MC-1 for CABG, but no money to move forward the rest of the pipeline.

If they find the right way to finance those, they will.
There are many ways to do that. They can do another secondary,
and if the share price increases substantially I am sure they will do that. They can partner MC-4232.
They will need to that anyway at some point. A blood pressure medication need a big pharma for partnering. They can They can partner MC-1 for ROW, etc.

If I were even dumber than I am I would point out that your arguments do not support your belief of partnering MC-1 in USA.
But since I am way overweight in the stock, and has no intention to increase that even at this ridiculous price, my interest is the stock price increase.

Belief tht Medicure soon partner MC-1 potentialy increase
the share price. Although I believe that the current share price also indicates that nobody really believes that anymore.
So I have no intention to dissuade anybody about believing that partnering is imminent. Of course I
Dunno
anything anyway.